THNUY yields 9.46% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, THNUY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of THNUY + JNJ for your $10,000?
Thanachart Capital Public Company Limited, an investment holding company, provides various financial services in Thailand. It operates through six segments: Company, Securities Business, Life Insurance Business, Non-Life Insurance Business, Asset Management Business, and Hire Purchase and Leasing Business. The company offers commercial banking and asset management services; securities and derivatives brokerage, proprietary trading, borrowing and lending, and investment and financial advisory services, as well as operates as an underwriting and securities registrar. It also provides non-life insurance products in the areas of fire, automobile, marine and transportation, and miscellaneous; life and health insurance products to individuals, institutions, and organizations; and hire purchase and financials leasing services for passenger cars, as well as vehicles for commercial purposes, such as pick-ups, taxis, truck tractors and lorries, etc. The company was formerly known as National Finance Public Company Limited and changed its name to Thanachart Capital Public Company Limited in April 2006. Thanachart Capital Public Company Limited was incorporated in 1959 and is headquartered in Bangkok, Thailand.
Full THNUY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.